may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful.
"the big unanswered question is concerns over safety in pregnancy," she says. cgrp levels are lower than normal in pregnant women who have.
he has worked with patients under similar circumstances, but is not involved in the first lady’s case..